Furthermore, BTG1 mRNA is downregulated in several solid tumors, including thyroid, lung, nasopharyngeal and breast cancer, while decreased expression is correlated with poor overall survival or increased cellular invasion [30–34]. This evidence concerns the gene BTG1 and breast cancer.